MOPA — Medical Oncology Prior Authorization
0.1.1-snapshot-080926 - snapshot-080926 United States of America flag

MOPA — Medical Oncology Prior Authorization - Local Development build (v0.1.1-snapshot-080926) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Example Regimen Order: ddAC→T (Jane Smith, Adjuvant) — Sequential Phases

Raw xml | Download


<RequestGroup xmlns="http://hl7.org/fhir">
  <id value="DDACTRegimenOrder"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/us/codex-mopa/StructureDefinition/anticancer-regimen-requestgroup"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: RequestGroup DDACTRegimenOrder</b></p><a name="DDACTRegimenOrder"> </a><a name="hcDDACTRegimenOrder"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-anticancer-regimen-requestgroup.html">Anti-Cancer Regimen RequestGroup</a></p></div><p><b>Request Category</b>: <span title="Codes:{http://snomed.info/sct 373846009}">Adjuvant - intent</span></p><p><b>Request Category</b>: <span title="Codes:{http://hl7.org/fhir/us/codex-mopa/CodeSystem/treatment-line-cs 1L}">First-line</span></p><p><b>instantiatesCanonical</b>: <a href="PlanDefinition-RegimenDdACT.html">ddAC→T: Dose-Dense Doxorubicin/Cyclophosphamide then Paclitaxel — Breast Cancer</a></p><p><b>status</b>: Draft</p><p><b>intent</b>: Order</p><p><b>subject</b>: <a href="Patient-MOPAPatientExample.html">Jane Smith (official) Female, DoB: 1968-04-15 ( http://hospital.example.org/patients#MRN-78432)</a></p><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>ac-phase-order</blockquote><p><b>title</b>: AC Phase (Cycles 1–4, q14d)</p><p><b>timing</b>: Count 4  times, Once per 14 days</p><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>doxorubicin-action</blockquote><p><b>title</b>: Doxorubicin 60 mg/m² IV day 1</p><p><b>timing</b>: Once per 14 days</p><p><b>resource</b>: <a href="MedicationRequest-DoxorubicinMedRequestDDACT.html">MedicationRequest: status = draft; intent = order; medication[x] = doxorubicin</a></p></blockquote><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>cyclophosphamide-action</blockquote><p><b>title</b>: Cyclophosphamide 600 mg/m² IV day 1</p><p><b>timing</b>: Once per 14 days</p><p><b>resource</b>: <a href="MedicationRequest-CyclophosphamideMedRequestDDACT.html">MedicationRequest: status = draft; intent = order; medication[x] = cyclophosphamide</a></p></blockquote><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>pegfilgrastim-action</blockquote><p><b>title</b>: Pegfilgrastim 6 mg subcutaneous day 2</p><p><b>timing</b>: Once per 14 days</p><p><b>resource</b>: <a href="MedicationRequest-PegfilgrastimMedRequestDDACT.html">MedicationRequest: status = draft; intent = order; medication[x] = pegfilgrastim</a></p></blockquote></blockquote><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>t-phase-order</blockquote><p><b>title</b>: T Phase — Paclitaxel (Cycles 5–8, q14d)</p><h3>RelatedActions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>ActionId</b></td><td><b>Relationship</b></td></tr><tr><td style="display: none">*</td><td>ac-phase-order</td><td>After End</td></tr></table><p><b>timing</b>: Count 4  times, Once per 14 days</p><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>paclitaxel-t-action</blockquote><p><b>title</b>: Paclitaxel 175 mg/m² IV day 1</p><p><b>timing</b>: Once per 14 days</p><p><b>resource</b>: <a href="MedicationRequest-PaclitaxelMedRequestTPHase.html">MedicationRequest: status = draft; intent = order; medication[x] = paclitaxel</a></p></blockquote></blockquote></div>
  </text>
  <extension
             url="http://hl7.org/fhir/us/davinci-crd/StructureDefinition/ext-request-category">
    <valueCodeableConcept>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="373846009"/>
        <display value="Adjuvant - intent"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <extension
             url="http://hl7.org/fhir/us/davinci-crd/StructureDefinition/ext-request-category">
    <valueCodeableConcept>
      <coding>
        <system
                value="http://hl7.org/fhir/us/codex-mopa/CodeSystem/treatment-line-cs"/>
        <code value="1L"/>
        <display value="First-line"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <instantiatesCanonical
                         value="http://hl7.org/fhir/us/codex-mopa/PlanDefinition/RegimenDdACT"/>
  <status value="draft"/>
  <intent value="order"/>
  <subject>🔗 
    <reference value="Patient/MOPAPatientExample"/>
  </subject>
  <action id="ac-phase-order">
    <title value="AC Phase (Cycles 1–4, q14d)"/>
    <timingTiming>
      <repeat>
        <count value="4"/>
        <period value="14"/>
        <periodUnit value="d"/>
      </repeat>
    </timingTiming>
    <action id="doxorubicin-action">
      <title value="Doxorubicin 60 mg/m² IV day 1"/>
      <timingTiming>
        <extension
                   url="http://hl7.org/fhir/us/codex-mopa/StructureDefinition/regimen-days-of-cycle">
          <extension url="day">
            <valueInteger value="1"/>
          </extension>
        </extension>
        <repeat>
          <period value="14"/>
          <periodUnit value="d"/>
        </repeat>
      </timingTiming>
      <resource>🔗 
        <reference value="MedicationRequest/DoxorubicinMedRequestDDACT"/>
      </resource>
    </action>
    <action id="cyclophosphamide-action">
      <title value="Cyclophosphamide 600 mg/m² IV day 1"/>
      <timingTiming>
        <extension
                   url="http://hl7.org/fhir/us/codex-mopa/StructureDefinition/regimen-days-of-cycle">
          <extension url="day">
            <valueInteger value="1"/>
          </extension>
        </extension>
        <repeat>
          <period value="14"/>
          <periodUnit value="d"/>
        </repeat>
      </timingTiming>
      <resource>🔗 
        <reference value="MedicationRequest/CyclophosphamideMedRequestDDACT"/>
      </resource>
    </action>
    <action id="pegfilgrastim-action">
      <title value="Pegfilgrastim 6 mg subcutaneous day 2"/>
      <timingTiming>
        <extension
                   url="http://hl7.org/fhir/us/codex-mopa/StructureDefinition/regimen-days-of-cycle">
          <extension url="day">
            <valueInteger value="2"/>
          </extension>
        </extension>
        <repeat>
          <period value="14"/>
          <periodUnit value="d"/>
        </repeat>
      </timingTiming>
      <resource>🔗 
        <reference value="MedicationRequest/PegfilgrastimMedRequestDDACT"/>
      </resource>
    </action>
  </action>
  <action id="t-phase-order">
    <title value="T Phase — Paclitaxel (Cycles 5–8, q14d)"/>
    <relatedAction>
      <actionId value="ac-phase-order"/>
      <relationship value="after-end"/>
    </relatedAction>
    <timingTiming>
      <repeat>
        <count value="4"/>
        <period value="14"/>
        <periodUnit value="d"/>
      </repeat>
    </timingTiming>
    <action id="paclitaxel-t-action">
      <title value="Paclitaxel 175 mg/m² IV day 1"/>
      <timingTiming>
        <extension
                   url="http://hl7.org/fhir/us/codex-mopa/StructureDefinition/regimen-days-of-cycle">
          <extension url="day">
            <valueInteger value="1"/>
          </extension>
        </extension>
        <repeat>
          <period value="14"/>
          <periodUnit value="d"/>
        </repeat>
      </timingTiming>
      <resource>🔗 
        <reference value="MedicationRequest/PaclitaxelMedRequestTPHase"/>
      </resource>
    </action>
  </action>
</RequestGroup>